VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CNC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CNCCentene Corp.
$69.74$34.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
CNC logo

Centene Corp.

CNC
NYSE · Health Insurers
$69.74
At close - Nov 6, 4:00 PM EST - USD
Market Cap$34.45B
P/E23.6x
52W High$78.08
Volume5.81M
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q3

Reserve Shock Undermines Centene Recovery Thesis

Centene's fundamentals appear structurally impaired after 2025Q3's $7.0 billion operating loss at a 114.0% combined ratio, and the recovery narrative has already been complicated by 2026Q3's return to a 100.6% loss ratio and a $307 million operating loss.

GrowthMixed
ProfitabilityWeak
ValuationAttractive
TechnicalsStrong
Explore valuation models
MARKET ACTION

CNC price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

11/12 Beats

EPS beat 11 of last 12 quarters

02

Valuation risk

In Line

P/E is in line with peer median

03

Market leadership

RS 87 · Leader

High momentum (Outperforming 87% of market)

04

Strong Uptrend

Strong Trend

Price > 20DMA > 50DMA > 200DMA

Next CatalystEstimated earnings · Jan 27
01

Build the investment case

Start with the evidence for owning the stock and the risks that can break the thesis.

EXECUTIVE THESIS

The Investment Case

Full Analysis
Fundamental Trajectory

Revenue growth collapsed to 1.9% year-over-year in 2026Q3 from 22.4% in 2025Q2, while the loss ratio swung 22.5 percentage points from 78.1% in 2026Q1 to 100.6% in 2026Q3, suggesting the reported 96.3%–96.9% combined ratios in early 2026 may not reflect sustainable underwriting economics.

Analyst Consensus+8.2% target
Buy(44 analysts)
27 Buy16 Hold1 Sell

The Bull Case

Upside Catalysts

Undervalued Stock Price and Potential for Rebound

Centene's stock has experienced a significant decline, reaching near decade-lows. This depressed valuation, coupled with positive catalysts, suggests substantial upside potential, with some analyses indicating the stock could potentially double, returning to previous trading ranges.

ACA Rate Increases and Margin Recovery

Anticipated increases in Affordable Care Act (ACA) rates are expected to drive a significant earnings rebound in 2026. Early state approvals suggest average price hikes of approximately 27% for Centene's ACA business, which could substantially improve ACA margins and revenues.

Operational Improvements and Normalization

Centene is expected to benefit from normalized utilization trends in its insurance pools. The company has implemented initiatives such as an ABA task force and clinical management programs to improve efficiency, with a key indicator being the Medicaid Health Benefits Ratio (HBR) remaining at or below 93.7% in Q1 2026.

The Bear Case

Key Downside Risks

Market performance

Price History →

Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
CNC+66.83%
S&P 500 (^GSPC)+7.63%
1-Year Return
CNC+87.87%
S&P 500 (^GSPC)+9.69%
3-Year Return
CNC-2.98%
S&P 500 (^GSPC)+60.10%
5-Year Return
CNC-5.91%
S&P 500 (^GSPC)+48.14%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/EMedian
23.6x
Forward P/EExpansion
13.2x
EV/EBITDA50th %ile
14.6x
FCF YieldCash Flow
11.5%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
23.6x
36.1x
50th· Fair
EV/EBITDA
14.6x
17.9x
50th· Fair
Price/FCF
8.7x
9.1x
50th· Fair
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$57.21-18.0%
Base (Fair)$87.92+26.1%
Bull$158.56+127.4%
$57.21 Bear$87.92 Base$158.56 Bull
Current Market Price: $69.74
Trades at a 20.7% discount to Base DCF ($87.92)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$194.78B+19.4% YoY
Net income FY25
-$6.67B-301.9% YoY
Free cash flow FY25
$4.32B+981.8% YoY
Operating margin FY25
-3.9%-5.9 pts YoY
ROIC (FY25)-21.6%
Avg ROIC 5Y0%
ROE (TTM)6.8%
Piotroski Score6 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate11/12 (92%)
Revenue Beat Rate12/12 (100%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Oct 27, 2026
$0.58+506.1%
vs $0.10
$50.6B+7.5%
vs $47.1B
Q3 2026
Jul 28, 2026
$2.51+130.3%
vs $1.09
$53.6B+12.5%
vs $47.6B
Q2 2026
Apr 28, 2026
$3.37+51.1%
vs $2.23
$49.9B+5.1%
vs $47.5B
Q1 2026
Feb 6, 2026
-$1.19+2.5%
vs -$1.22
$49.7B+2.7%
vs $48.4B
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Seeking Alpha·Oct 27, 2026
Centene Corporation (CNC) Q3 2026 Earnings Call Transcript

Centene Corporation (CNC) Q3 2026 Earnings Call Transcript

Benzinga·Oct 27, 2026
Centene Stock Approaches 52-Week High on Faster-Than-Expected Earnings Recovery

U.S. health care insurance provider Centene Corporation (NYSE:CNC) reported better-than-expected third-quarter earnings, with adjusted earnings of 58 cents, beating the consensus of 10 cents per share.

Zacks Investment Research·Oct 27, 2026
Compared to Estimates, Centene (CNC) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Centene (CNC) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research·Oct 27, 2026
Centene (CNC) Q3 Earnings and Revenues Surpass Estimates

Centene (CNC) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.5 per share a year ago.

Filtered for Centene Corp.More Headlines
04

Compare before deciding

Benchmark CNC against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Centene Corp. (CNC)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
CNC logoCNCCentene Corp.Current
$69.74$34.45B23.5919.44%0.75%6.76%—
MOH logoMOHMolina Healthcare, Inc.
$208.99$10.91B-224.2411.75%-0.11%-1.17%—
UNH logoUNHUnitedHealth Group Incorporated
$394.15$357.95B22.3811.81%3.53%15.18%2.21%
ELV logoELVElevance Health Inc.
$425.62$92.3B18.0212.62%2.55%11.56%1.62%
HUM logoHUMHumana Inc.
$433.74$52.08B42.4410.06%0.81%6.68%0.82%
CVS logoCVSCVS Health Corp.
$83.85$106.99B9.797.85%2.63%14.1%3.19%

Compare CNC vs Peers

Centene Corp. (CNC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs MOH

Most directly comparable listed peer for CNC.

Scale Benchmark

vs UNH

Larger-name benchmark to compare CNC against a more recognizable public peer.

Peer Set

Compare Top 5

vs MOH, UNH, ELV, HUM

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

CNC SEC Filings & Documents

Centene Corp. (CNC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Oct 27, 2026·SEC

Material company update

Oct 8, 2026·SEC

Material company update

Aug 17, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 17, 2026·SEC

FY 2025

Feb 18, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

Oct 27, 2026·SEC

FY 2026

Jul 28, 2026·SEC

FY 2026

Apr 28, 2026·SEC

Get notified when CNC posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CNC Frequently Asked Questions

Centene Corp. (CNC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
How fast is Centene Corp. growing?

Centene Corp. (CNC) grew revenue by 4.8% over the trailing twelve months, compared with the twelve months before.

Is CNC profitable?

Yes. Centene Corp. (CNC) earned $1.46B in net income over the trailing twelve months (a 0.8% net margin).

Dividend & Returns
What is CNC's return on equity?

Centene Corp. (CNC) had a return on equity (ROE) of 6.8% over the trailing twelve months. That is below the market's typical 10-15%.

Industry Metrics
What is Centene Corp.'s combined ratio?

Centene Corp. (CNC) has a combined ratio of 103.9%. A ratio above 100% means claims and expenses exceed premiums.

What if you invested $1,000 in CNC back in 2000?

Total return calculator · dividends reinvested · 26+ years of data

See returns →